Mathai Mammen is the CEO and President at FogPharma. With over 25 years of experience in biopharmaceuticals, he has a strong track record of creating transformational medicines and building successful businesses. He values creativity, focused risk-taking, and a patient-centered approach, inspiring world-class teams to improve global human health through advanced medicines and preventative treatments.